Evidence map›Paper›PMID 30382870›Full record

ArticleBMC biology2018

Evolving eukaryotes: an interview with Joel Dacks.

Joel B Dacks

Abstract readBiographyHistorical ArticleInterview
In one paragraph

Article in BMC biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joel B DacksFaculty of Medicine and Dentistry, University of Alberta, 5-31 Medical Science Building, Edmonton, Alberta, Canada. dacks@ualberta.ca.ORCID 0000-0003-4520-5694

Funding

Measuring Design, Reporting and Funding Bias in Nonclinical ResearchR21ES021028 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BERO, LISA A · 2011 to 2012
$425k
NIEHS NIH HHS R21 ES021028
6 · The paper itself

Abstract

Joel Dacks is an Associate Professor and Canada Research Chair in Evolutionary Cell Biology at the University of Alberta, a Scientific Associate at the Natural History Museum (London), and the current President of the International Society for Evolutionary Protistology. His research group studies the evolution and diversity of the eukaryotic membrane-trafficking system, from origins to potential disease therapeutics. In this interview, Joel shares some perspectives on gaining a balanced view of comparative cell biology and the importance of a constructive peer review process.

Indexed as

AlbertaBiological TransportCell BiologyEukaryotaHistory, 21st CenturyLondonMembranesPeer Review, ResearchEukaryotesEvolutionGenomicsGolgiMembrane-traffickingParasitism

Identifiers

PMID30382870
PMCPMC6211498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.